Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00422487
Status:
COMPLETED
Last Update Posted:
2015-05-01
First Post:
2007-01-15
Brief Title:
Safety and Tolerability Study of MBX-2044 in Patients With Type 2 Diabetes
Sponsor:
CymaBay Therapeutics Inc
Organization:
CymaBay Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-10
Start Date Type:
None
Primary Completion Date:
2007-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-09
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-15
First Submit QC Date:
January 15 2007
Study First Post Date:
2007-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-29
Last Update Post Date:
2015-05-01
Last Update Post Date Type:
ESTIMATED